Zhejiang Huakang Pharmaceutical Co., Ltd.

Shanghai Stock Exchange 605077.SS

Zhejiang Huakang Pharmaceutical Co., Ltd. Inventory for the year ending December 31, 2023: USD 39.73 M

Zhejiang Huakang Pharmaceutical Co., Ltd. Inventory is USD 39.73 M for the year ending December 31, 2023, a -1.76% change year over year. Inventory is the value of goods held by a company for sale or used in the production process.
  • Zhejiang Huakang Pharmaceutical Co., Ltd. Inventory for the year ending December 31, 2022 was USD 40.44 M, a 28.64% change year over year.
  • Zhejiang Huakang Pharmaceutical Co., Ltd. Inventory for the year ending December 31, 2021 was USD 31.43 M, a 35.51% change year over year.
  • Zhejiang Huakang Pharmaceutical Co., Ltd. Inventory for the year ending December 31, 2020 was USD 23.20 M, a -1.55% change year over year.
  • Zhejiang Huakang Pharmaceutical Co., Ltd. Inventory for the year ending December 31, 2019 was USD 23.56 M, a 29.67% change year over year.
Key data
Date Inventory Goodwill Total Assets Current Liabilities
Market news
SV Wall Street
Shanghai Stock Exchange: 605077.SS

Zhejiang Huakang Pharmaceutical Co., Ltd.

CEO Mr. Deshui Chen
IPO Date Feb. 9, 2021
Location China
Headquarters No.18, Huagong Road
Employees 1,350
Sector Consumers Staples
Industries
Non-Alcoholic Beverages Alcoholic Beverages Biofuel Chemicals & Advanced Materials Food & Beverages Glass Plastics Soft Drinks & Sodas
Description

Zhejiang Huakang Pharmaceutical Co., Ltd. engages in the research, production, and sale of polyols worldwide. Its products include xylitol, a polyol with close to sugar sweetness; sorbitol, a sugar alcohol being white crystal powder; maltitol, a sugar alcohol; xylose that is used in xylitol production; and L-arabinos, which can be used as sucrose replacement or additives. The company is based in Kaihua County, China.

StockViz Staff

February 2, 2025

Any question? Send us an email